{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:32:43Z","timestamp":1792758763516,"version":"4.5.0"},"reference-count":199,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1111\/1469-0691.12371","type":"journal-article","created":{"date-parts":[[2014,1,30]],"date-time":"2014-01-30T15:44:36Z","timestamp":1391096676000},"page":"5-26","source":"Crossref","is-referenced-by-count":589,"special_numbering":"S3","title":["ESCMID\u2020 and ECMM\u2021 joint clinical guidelines for the diagnosis and management of mucormycosis 2013"],"prefix":"10.1016","volume":"20","author":[{"given":"O.A.","family":"Cornely","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Arikan-Akdagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Dannaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.H.","family":"Groll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Lagrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Lanternier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Skiada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Akova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Arendrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Boekhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Chowdhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cuenca-Estrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Freiberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Guinea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Guarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"de Hoog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kathuria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lackner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lass-Fl\u00f6rl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.F.","family":"Meis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Meletiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Roilides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Tortorano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"Ullmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"van Diepeningen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Petrikkos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/1469-0691.12371_bib1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1439-0507.2012.02231.x","article-title":"Right flank pain and high fever in a neutropenic patient with acute lymphoblastic leukaemia","volume":"56","author":"Christopeit","year":"2013","journal-title":"Mycoses"},{"key":"10.1111\/1469-0691.12371_bib2","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1056\/NEJMoa1204781","article-title":"Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011","volume":"367","author":"Neblett Fanfair","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12371_bib3","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2307\/3758897","article-title":"The zygomycete Saksenaea vasiformis as a pathogen of humans with a critical review of the etiology of zygomycosis","volume":"68","author":"Ajello","year":"1976","journal-title":"Mycologia"},{"key":"10.1111\/1469-0691.12371_bib5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1128\/CMR.00056-10","article-title":"Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species","volume":"24","author":"Gomes","year":"2011","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl. 1","key":"10.1111\/1469-0691.12371_bib6","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1093\/cid\/cir864","article-title":"Taxonomy of fungi causing mucormycosis and entomophthoramycosis (zygomycosis) and nomenclature of the disease: molecular mycologic perspectives","volume":"54","author":"Kwon-Chung","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib7","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1469-0691.2010.03456.x","article-title":"Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007","volume":"17","author":"Skiada","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12371_bib8","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1128\/JCM.01272-09","article-title":"Cavitary pulmonary zygomycosis caused by Rhizopus homothallicus","volume":"48","author":"Chakrabarti","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12371_bib9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0272-6386(12)70141-5","article-title":"Renal mucormycosis: computerized tomographic findings and their diagnostic significance","volume":"22","author":"Chugh","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/1469-0691.12371_bib10","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1259\/bjr\/17821080","article-title":"Isolated renal mucormycosis: an unusual cause of acute renal infarction in a boy with aplastic anaemia","volume":"79","author":"Sharma","year":"2006","journal-title":"Br J Radiol"},{"key":"10.1111\/1469-0691.12371_bib11","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3109\/13693781003753477","article-title":"Successful medical management of renal zygomycosis: a summary of two cases and a review of the Indian literature","volume":"48","author":"Marak","year":"2010","journal-title":"Med Mycol"},{"issue":"Suppl. 1","key":"10.1111\/1469-0691.12371_bib17","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54","author":"Petrikkos","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib18","first-page":"543","article-title":"Mycosis mucorina. Ein Beitrag zur Kenntniss der menschlichen Fadenpilzerkrankungen","volume":"102","author":"Paltauf","year":"1885","journal-title":"Archiv f\u00fcr pathologische Anatomie"},{"key":"10.1111\/1469-0691.12371_bib19","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3201\/eid1509.090334","article-title":"Increasing incidence of zygomycosis (mucormycosis), France, 1997\u20132006","volume":"15","author":"Bitar","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib20","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/clinids\/27.5.1138","article-title":"The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992\u20131993: results of population-based laboratory active surveillance","volume":"27","author":"Rees","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib21","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1128\/AAC.01539-06","article-title":"In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest","volume":"51","author":"Torres-Narbona","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib22","first-page":"862","article-title":"Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program","volume":"86","author":"Pagano","year":"2001","journal-title":"Haematologica"},{"key":"10.1111\/1469-0691.12371_bib23","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/myc.12081","article-title":"Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study","volume":"56","author":"Lewis","year":"2013","journal-title":"Mycoses"},{"key":"10.1111\/1469-0691.12371_bib24","article-title":"Risk factors for early mortality in haematological malignancy patients with pulmonary mucormycosis","author":"Lewis","year":"2013","journal-title":"Mycoses"},{"issue":"Suppl. 1","key":"10.1111\/1469-0691.12371_bib25","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/cid\/cir880","article-title":"A global analysis of mucormycosis in France: the RetroZygo Study (2005\u20132007)","volume":"54","author":"Lanternier","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib26","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/jac\/dkp430","article-title":"Forty-one recent cases of invasive zygomycosis from a global clinical registry","volume":"65","author":"R\u00fcping","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12371_bib27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 7","key":"10.1111\/1469-0691.12371_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12037","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases","volume":"18","author":"Ullmann","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12371_bib29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1469-0691.2005.01321.x","article-title":"Comparison of two fluorescent whiteners, Calcofluor and Blankophor, for the detection of fungal elements in clinical specimens in the diagnostic laboratory","volume":"12","author":"Hamer","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12371_bib30","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1086\/521245","article-title":"The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients","volume":"45","author":"Lass-Florl","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib31","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1016\/j.tripleo.2009.11.012","article-title":"Successful treatment of periodontal mucormycosis: report of a case and literature review","volume":"109","author":"McDermott","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1111\/1469-0691.12371_bib32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/CMR.13.2.236-301.2000","article-title":"Zygomycetes in human disease","volume":"13","author":"Ribes","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/1469-0691.12371_bib33","series-title":"Medically important fungi: a guide to identification","author":"Larone","year":"2011"},{"key":"10.1111\/1469-0691.12371_bib36","doi-asserted-by":"crossref","first-page":"375","DOI":"10.5858\/2001-125-0375-HFOZ","article-title":"Histologic features of zygomycosis: emphasis on perineural invasion and fungal morphology","volume":"125","author":"Frater","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"10.1111\/1469-0691.12371_bib37","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jinf.2009.06.002","article-title":"A clinicopathological study of pulmonary mucormycosis in cancer patients: extensive angioinvasion but limited inflammatory response","volume":"59","author":"Ben-Ami","year":"2009","journal-title":"J Infect"},{"key":"10.1111\/1469-0691.12371_bib38","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/pgmj.2008.076463","article-title":"Invasive zygomycosis in India: experience in a tertiary care hospital","volume":"85","author":"Chakrabarti","year":"2009","journal-title":"Postgrad Med J"},{"key":"10.1111\/1469-0691.12371_bib39","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/(SICI)1096-9896(199701)181:1<100::AID-PATH100>3.0.CO;2-O","article-title":"The use of immunohistochemistry to improve sensitivity and specificity in the diagnosis of systemic mycoses in patients with haematological malignancies","volume":"181","author":"Jensen","year":"1997","journal-title":"J Pathol"},{"key":"10.1111\/1469-0691.12371_bib40","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/myc.12048","article-title":"Serum galactomannan assay for the diagnosis of invasive aspergillosis in children with haematological malignancies","volume":"56","author":"Jha","year":"2013","journal-title":"Mycoses"},{"key":"10.1111\/1469-0691.12371_bib41","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1399-3062.2007.00264.x","article-title":"Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy\u2013driven survey","volume":"10","author":"Sinko","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib42","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1086\/430826","article-title":"Evaluation of serum sandwich enzyme-linked immunosorbent assay for circulating galactomannan during caspofungin therapy: results from the caspofungin invasive aspergillosis study","volume":"41","author":"Maertens","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib43","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jinf.2011.12.015","article-title":"Breakthrough invasive mould infections in patients treated with caspofungin","volume":"64","author":"Pang","year":"2012","journal-title":"J Infect"},{"key":"10.1111\/1469-0691.12371_bib44","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/13693780500474327","article-title":"Differences in \u03b2-glucan levels in culture supernatants of a variety of fungi","volume":"44","author":"Odabasi","year":"2006","journal-title":"Med Mycol"},{"key":"10.1111\/1469-0691.12371_bib45","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/432470","article-title":"Multicenter clinical evaluation of the (1\u21923) \u03b2-D-glucan assay as an aid to diagnosis of fungal infections in humans","volume":"41","author":"Ostrosky-Zeichner","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib46","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1182\/blood-2011-07-366526","article-title":"Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patients","volume":"118","author":"Potenza","year":"2011","journal-title":"Blood"},{"key":"10.1111\/1469-0691.12371_bib47","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1086\/512812","article-title":"Comparison of histopathological analysis, culture, and polymerase chain reaction assays to detect invasive mold infections from biopsy specimens","volume":"44","author":"Rickerts","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib48","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1128\/JCM.00256-11","article-title":"Molecular methods to improve diagnosis and identification of mucormycosis","volume":"49","author":"Hammond","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12371_bib49","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1136\/jcp.2004.024703","article-title":"PCR based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue","volume":"58","author":"Bialek","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1111\/1469-0691.12371_bib50","doi-asserted-by":"crossref","first-page":"E271","DOI":"10.1111\/1469-0691.12110","article-title":"Efficacy of DNA amplification in tissue biopsy samples to improve the detection of invasive fungal disease","volume":"19","author":"Buitrago","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12371_bib51","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1128\/JCM.02319-09","volume":"48","author":"Dannaoui","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12371_bib52","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1128\/JCM.00917-08","article-title":"Detection of a molecular biomarker for zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis","volume":"46","author":"Kasai","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12371_bib53","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1128\/JCM.02219-06","article-title":"Carbon assimilation profiles as a tool for identification of zygomycetes","volume":"45","author":"Schwarz","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12371_bib54","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3109\/13693786.2012.690107","article-title":"Increased virulence of Cunninghamella bertholletiae in experimental pulmonary mucormycosis: correlation with circulating molecular biomarkers, sporangiospore germination and hyphal metabolism","volume":"51","author":"Petraitis","year":"2013","journal-title":"Med Mycol"},{"key":"10.1111\/1469-0691.12371_bib55","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1128\/JCM.02030-08","article-title":"Mucor circinelloides as a cause of invasive maxillofacial zygomycosis: an emerging dimorphic pathogen with reduced susceptibility to posaconazole","volume":"47","author":"Khan","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12371_bib56","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1128\/AAC.05956-11","article-title":"In vitro and in vivo activities of posaconazole and amphotericin B in a murine invasive infection by Mucor circinelloides: poor efficacy of posaconazole","volume":"56","author":"Salas","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib57","unstructured":"Lanternier F, Poiree S, Elie C et al. Pilot prospective study of high dose (10 mg\/kg\/day) liposomal amphotericin B for the initial treatment of mucormycosis: \u2018AMBIZYGO\u2019 Trial (M-1707). 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, 2012."},{"issue":"Suppl. 1","key":"10.1111\/1469-0691.12371_bib58","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1093\/cid\/cir867","article-title":"Healthcare-associated mucormycosis","volume":"54","author":"Rammaert","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib59","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1128\/JCM.02094-08","article-title":"Molecular and phenotypic evaluation of Lichtheimia corymbifera (formerly Absidia corymbifera) complex isolates associated with human mucormycosis: rehabilitation of L. ramosa","volume":"47","author":"Garcia-Hermoso","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12371_bib63","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1128\/JCM.26.9.1861-1863.1988","article-title":"Simple method of inducing sporulation by Apophysomyces elegans and Saksenaea vasiformis","volume":"26","author":"Padhye","year":"1988","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12371_bib64","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/428780","article-title":"Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case\u2013control observational study of 27 recent cases","volume":"191","author":"Kontoyiannis","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib65","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1128\/JCM.00036-09","article-title":"Spectrum of zygomycete species identified in clinically significant specimens in the United States","volume":"47","author":"Alvarez","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12371_bib66","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1128\/JCM.44.2.340-349.2006","article-title":"Molecular identification of Zygomycetes from culture and experimentally infected tissues","volume":"44","author":"Schwarz","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12371_bib67","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/JCM.41.2.783-788.2003","article-title":"Apophysomyces elegans: an emerging zygomycete in India","volume":"41","author":"Chakrabarti","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12371_bib68","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jdermsci.2005.01.010","article-title":"Genetic identification and detection of human pathogenic Rhizopus species, a major mucormycosis agent, by multiplex PCR based on internal transcribed spacer region of rRNA gene","volume":"39","author":"Nagao","year":"2005","journal-title":"J Dermatol Sci"},{"key":"10.1111\/1469-0691.12371_bib69","series-title":"Interpretive criteria for bacteria and fungi identification by DNA target sequencing","author":"CLSI","year":"2008"},{"key":"10.1111\/1469-0691.12371_bib70","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1128\/JCM.01685-08","article-title":"Sequence-based identification of Aspergillus, Fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here?","volume":"47","author":"Balajee","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12371_bib71","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1128\/JCM.37.12.3957-3964.1999","article-title":"Phylogeny and PCR identification of clinically important Zygomycetes based on nuclear ribosomal-DNA sequence data","volume":"37","author":"Voigt","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12371_bib72","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1128\/JCM.44.3.805-810.2006","article-title":"Genetic identification of the main opportunistic mucorales by PCR-restriction fragment length polymorphism","volume":"44","author":"Machouart","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12371_bib73","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1128\/JCM.42.2.622-626.2004","article-title":"Experience with the MicroSeq D2 large-subunit ribosomal DNA sequencing kit for identification of filamentous fungi encountered in the clinical laboratory","volume":"42","author":"Hall","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12371_bib74","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1128\/JCM.02331-07","article-title":"Real-time PCR method for detection of zygomycetes","volume":"46","author":"Hata","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12371_bib75","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1469-0691.2007.01932.x","article-title":"High-affinity iron permease (FTR1) gene sequence-based molecular identification of clinically important Zygomycetes","volume":"14","author":"Nyilasi","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12371_bib76","doi-asserted-by":"crossref","first-page":"e28425","DOI":"10.1371\/journal.pone.0028425","article-title":"Mould routine identification in the clinical laboratory by matrix-assisted laser desorption ionization time-of-flight mass spectrometry","volume":"6","author":"Cassagne","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1111\/1469-0691.12371_bib77","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1469-0691.2011.03599.x","article-title":"Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-of-flight mass spectrometry","volume":"18","author":"De Carolis","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12371_bib78","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1128\/JCM.01070-11","article-title":"Direct analysis and identification of pathogenic Lichtheimia species by matrix-assisted laser desorption ionization-time of flight analyzer-mediated mass spectrometry","volume":"50","author":"Schrodl","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12371_bib79","series-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. CLSI Document M38-A2","author":"CLSI","year":"2008"},{"key":"10.1111\/1469-0691.12371_bib80","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1469-0691.2008.02086.x","article-title":"EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds","volume":"14","author":"Rodriquez Tudela","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12371_bib81","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/JCM.44.2.553-560.2006","article-title":"Rapid susceptibility testing of medically important zygomycetes by XTT assay","volume":"44","author":"Antachopoulos","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12371_bib82","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1093\/jac\/dkq276","article-title":"In vitro and in vivo activities of posaconazole against zygomycetes with various degrees of susceptibility","volume":"65","author":"Spreghini","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12371_bib83","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/JCM.01420-10","article-title":"Apophysomyces elegans: epidemiology, amplified fragment length polymorphism typing, and in vitro antifungal susceptibility pattern","volume":"48","author":"Chakrabarti","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12371_bib84","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1128\/AAC.01026-09","article-title":"Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection","volume":"53","author":"Rodriguez","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib85","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1128\/AAC.01463-09","article-title":"Correlation between in vitro activity of posaconazole and in vivo efficacy against Rhizopus oryzae infection in mice","volume":"54","author":"Rodriguez","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib86","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1128\/AAC.46.5.1581-1582.2002","article-title":"In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes","volume":"46","author":"Sun","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib87","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1128\/AAC.00452-07","article-title":"In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents","volume":"51","author":"Almyroudis","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib88","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/jac\/dkg020","article-title":"In vitro susceptibilities of zygomycetes to conventional and new antifungals","volume":"51","author":"Dannaoui","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12371_bib89","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/13693780801975576","article-title":"Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus","volume":"46","author":"Arikan","year":"2008","journal-title":"Med Mycol"},{"key":"10.1111\/1469-0691.12371_bib90","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/JCM.06133-11","article-title":"Antifungal susceptibility and phylogeny of opportunistic members of the order Mucorales","volume":"50","author":"Vitale","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12371_bib91","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/jac\/dks137","article-title":"In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs","volume":"67","author":"Drogari-Apiranthitou","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12371_bib92","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1128\/AAC.01467-08","article-title":"Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers","volume":"53","author":"Alastruey-Izquierdo","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib93","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1128\/AAC.00786-10","article-title":"In vitro and in vivo antifungal susceptibilities of the Mucoralean fungus Cunninghamella","volume":"54","author":"Pastor","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib94","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1128\/AAC.49.2.830-832.2005","article-title":"Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice","volume":"49","author":"Spellberg","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib95","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1128\/AAC.00628-08","article-title":"Posaconazole combined with amphotericin B, an effective therapy for a murine disseminated infection caused by Rhizopus oryzae","volume":"52","author":"Rodriguez","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib96","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1128\/AAC.46.8.2708-2711.2002","article-title":"In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents","volume":"46","author":"Dannaoui","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib97","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1128\/AAC.00492-08","article-title":"Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro","volume":"52","author":"Perkhofer","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib98","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1128\/AAC.00595-07","article-title":"Synergistic effect of posaconazole and caspofungin against clinical zygomycetes","volume":"51","author":"Guembe","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib99","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0732-8893(02)00509-6","article-title":"In vitro evaluation of combination of terbinafine with itraconazole or amphotericin B against Zygomycota","volume":"45","author":"Gomez-Lopez","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib100","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1128\/AAC.02612-12","article-title":"Drug combinations against Mucor irregularis in vitro","volume":"57","author":"Zhang","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib101","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"de Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib102","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1086\/430710","article-title":"Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer","volume":"41","author":"Chamilos","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib103","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1086\/587991","article-title":"Reversed halo sign in invasive pulmonary fungal infections","volume":"46","author":"Wahba","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib104","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1378\/chest.11-1050","article-title":"Reversed halo sign: high-resolution CT scan findings in 79 patients","volume":"141","author":"Marchiori","year":"2012","journal-title":"Chest"},{"key":"10.1111\/1469-0691.12371_bib105","first-page":"207","article-title":"Mucormycosis in hematologic patients","volume":"89","author":"Pagano","year":"2004","journal-title":"Haematologica"},{"key":"10.1111\/1469-0691.12371_bib106","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1148\/radiology.140.2.7255714","article-title":"CT scanning in rhinocerebral mucormycosis and aspergillosis","volume":"140","author":"Centeno","year":"1981","journal-title":"Radiology"},{"key":"10.1111\/1469-0691.12371_bib107","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1148\/radiology.160.1.3715034","article-title":"Craniofacial mucormycosis: assessment with CT","volume":"160","author":"Gamba","year":"1986","journal-title":"Radiology"},{"key":"10.1111\/1469-0691.12371_bib108","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-0028-1096209","article-title":"Imaging findings of rhinocerebral mucormycosis","volume":"19","author":"Herrera","year":"2009","journal-title":"Skull Base"},{"key":"10.1111\/1469-0691.12371_bib109","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1080\/00207450601050238","article-title":"Rhino-orbital-cerebral mucormycosis with different cerebral involvements: infarct, hemorrhage, and ophthalmoplegia","volume":"117","author":"Koc","year":"2007","journal-title":"Int J Neurosci"},{"key":"10.1111\/1469-0691.12371_bib110","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1439-0507.2007.01364.x","article-title":"Rhinocerebral mucormycosis: the disease spectrum in 27 patients","volume":"50","author":"Mohindra","year":"2007","journal-title":"Mycoses"},{"key":"10.1111\/1469-0691.12371_bib111","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12371_bib112","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease","volume":"356","author":"Ullmann","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12371_bib113","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/cid\/cis773","article-title":"Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry","volume":"55","author":"Pagano","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib114","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1439-0507.2005.01132.x","article-title":"In vitro susceptibility of 15 strains of zygomycetes to nine antifungal agents as determined by the NCCLS M38-A microdilution method","volume":"48","author":"Singh","year":"2005","journal-title":"Mycoses"},{"key":"10.1111\/1469-0691.12371_bib115","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1128\/AAC.01512-07","article-title":"In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species","volume":"52","author":"Guinea","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib116","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3109\/13693786.2011.583943","article-title":"Susceptibility of Candida species and various moulds to antimycotic drugs: use of epidemiological cutoff values according to EUCAST and CLSI in an 8-year survey","volume":"49","author":"Rambach","year":"2011","journal-title":"Med Mycol"},{"key":"10.1111\/1469-0691.12371_bib117","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/sj.bmt.1705655","article-title":"Surgical resection of persistent pulmonary fungus nodules and secondary prophylaxis are effective in preventing fungal relapse in patients receiving chemotherapy or bone marrow transplantation for leukemia","volume":"39","author":"Nosari","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/1469-0691.12371_bib118","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/(SICI)1096-911X(199704)28:4<268::AID-MPO5>3.0.CO;2-G","article-title":"Prior fungal infection is not a contraindication to bone marrow transplant in patients with acute leukemia","volume":"28","author":"Hoover","year":"1997","journal-title":"Med Pediatr Oncol"},{"issue":"Suppl. 7","key":"10.1111\/1469-0691.12371_bib119","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12371_bib120","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/0003-4975(94)90243-7","article-title":"Pulmonary mucormycosis: results of medical and surgical therapy","volume":"57","author":"Tedder","year":"1994","journal-title":"Ann Thorac Surg"},{"key":"10.1111\/1469-0691.12371_bib121","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/INF.0b013e318062115c","article-title":"Zygomycosis in children: a systematic review and analysis of reported cases","volume":"26","author":"Zaoutis","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/1469-0691.12371_bib122","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1128\/AAC.50.1.126-133.2006","article-title":"Posaconazole as salvage therapy for zygomycosis","volume":"50","author":"Greenberg","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib123","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1051\/medsci\/201329s107","article-title":"[Rhino-orbito-cerebral mucormycosis, surgical treatment, state of the art]","volume":"29","author":"Vironneau","year":"2013","journal-title":"Med Sci (Paris)"},{"key":"10.1111\/1469-0691.12371_bib124","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1128\/AAC.47.10.3343-3344.2003","article-title":"Liposomal amphotericin B, and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzae","volume":"47","author":"Ibrahim","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib125","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/AAC.01222-09","article-title":"Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis","volume":"54","author":"Lewis","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib126","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1128\/AAC.01488-07","article-title":"Comparison of lipid amphotericin B preparations in treating murine zygomycosis","volume":"52","author":"Ibrahim","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib127","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1086\/315643","article-title":"Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system","volume":"182","author":"Groll","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib128","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/514341","article-title":"Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBi-Load trial)","volume":"44","author":"Cornely","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 2","key":"10.1111\/1469-0691.12371_bib129","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/S0399-077X(08)73003-8","article-title":"AMBIZYGO: Phase II study of high dose liposomal amphotericin B (AmBisome) [10 mg\/kg\/day] efficacy against zygomycosis","volume":"38","author":"Lanternier","year":"2008","journal-title":"Med Mal Infect"},{"key":"10.1111\/1469-0691.12371_bib130","first-page":"201","article-title":"Efficacy and safety of amphotericin B lipid complex for zygomycosis","volume":"20","author":"Larkin","year":"2003","journal-title":"Infect Med"},{"key":"10.1111\/1469-0691.12371_bib131","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1128\/AAC.47.11.3647-3650.2003","article-title":"Activity of posaconazole in treatment of experimental disseminated zygomycosis","volume":"47","author":"Dannaoui","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib134","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1128\/AAC.50.2.658-666.2006","article-title":"Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection","volume":"50","author":"Ullmann","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib135","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/589857","article-title":"Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis","volume":"47","author":"Reed","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib136","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1086\/505969","article-title":"Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries","volume":"43","author":"Ullmann","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib137","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM199903113401004","article-title":"Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group","volume":"340","author":"Walsh","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12371_bib138","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1086\/590566","article-title":"Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria","volume":"47","author":"Segal","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib139","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1086\/500212","article-title":"Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases","volume":"42","author":"van Burik","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 5","key":"10.1111\/1469-0691.12371_bib140","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1469-0691.2009.02985.x","article-title":"Current experience in treating invasive zygomycosis with posaconazole","volume":"15","author":"Cornely","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12371_bib141","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/1040841X.2012.711741","article-title":"Mucormycosis treated with posaconazole: review of 96 case reports","volume":"39","author":"Vehreschild","year":"2012","journal-title":"Crit Rev Microbiol"},{"key":"10.1111\/1469-0691.12371_bib142","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1086\/516353","article-title":"Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases","volume":"26","author":"Walsh","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib143","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s100960100528","article-title":"Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion","volume":"20","author":"Herbrecht","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib144","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1128\/AAC.01124-08","article-title":"Posaconazole mono- or combination therapy for treatment of murine zygomycosis","volume":"53","author":"Ibrahim","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib145","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.3324\/haematol.2012.083063","article-title":"Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematological diseases: a report from the SEIFEM and FUNGISCOPE registries","volume":"98","author":"Pagano","year":"2013","journal-title":"Haematologica"},{"key":"10.1111\/1469-0691.12371_bib146","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1055\/s-0029-1220775","article-title":"Zygomycosis in neonates: an uncommon but life-threatening infection","volume":"26","author":"Roilides","year":"2009","journal-title":"Am J Perinatol"},{"key":"10.1111\/1469-0691.12371_bib148","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/MPH.0b013e3181bbc516","article-title":"Zygomycetes infections in pediatric hematology oncology patients: a case series and review of the literature","volume":"31","author":"Dehority","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1111\/1469-0691.12371_bib149","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/myc.12010","article-title":"Focus on invasive mucormycosis in paediatric haematology oncology patients: a series of 11 cases","volume":"56","author":"Phulpin-Weibel","year":"2013","journal-title":"Mycoses"},{"key":"10.1111\/1469-0691.12371_bib150","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1439-0507.2011.02124.x","article-title":"Trends in zygomycosis in children","volume":"55","author":"Prasad","year":"2012","journal-title":"Mycoses"},{"issue":"Suppl. 7","key":"10.1111\/1469-0691.12371_bib151","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/1469-0691.12040","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp","volume":"18","author":"Hope","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12371_bib152","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/13693780903311944","article-title":"Primary treatment of zygomycosis with liposomal amphotericin B: analysis of 28 cases","volume":"48","author":"Shoham","year":"2010","journal-title":"Med Mycol"},{"key":"10.1111\/1469-0691.12371_bib153","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1128\/AAC.41.9.1944","article-title":"Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis","volume":"41","author":"Walsh","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib154","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1128\/AAC.49.12.5092-5098.2005","article-title":"Population pharmacokinetics of amphotericin B lipid complex in neonates","volume":"49","author":"W\u00fcrthwein","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib155","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1128\/AAC.50.3.935-942.2006","article-title":"Population pharmacokinetics of liposomal amphotericin B in pediatric patients with malignant diseases","volume":"50","author":"Hong","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib156","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/00006454-199908000-00010","article-title":"Amphotericin B lipid complex in pediatric patients with invasive fungal infections","volume":"18","author":"Walsh","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/1469-0691.12371_bib157","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.inf.0000153183.51258.b8","article-title":"Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections","volume":"24","author":"Wiley","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/1469-0691.12371_bib158","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10096-003-0993-4","article-title":"High-dose liposomal amphotericin B in the therapy of systemic candidiasis in neonates","volume":"22","author":"Juster-Reicher","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib159","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/jac\/dkp196","article-title":"Safety, tolerance and outcome of treatment with liposomal amphotericin B in paediatric patients with cancer or undergoing haematopoietic stem cell transplantation","volume":"64","author":"Kolve","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12371_bib160","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1517\/14656566.8.15.2465","article-title":"Clinical pharmacology of antifungal agents in pediatric patients","volume":"8","author":"Chiou","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/1469-0691.12371_bib161","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1128\/AAC.00454-06","article-title":"Posaconazole plasma concentrations in juvenile patients with invasive fungal infection","volume":"51","author":"Krishna","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib162","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/INF.0b013e3182195808","article-title":"A twice daily posaconazole dosing algorithm for children with chronic granulomatous disease","volume":"30","author":"Welzen","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/1469-0691.12371_bib163","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/1471-2334-12-263","article-title":"Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation","volume":"12","author":"D\u00f6ring","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib164","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s10096-010-0957-4","article-title":"Posaconazole salvage treatment in paediatric patients: a multicentre survey","volume":"29","author":"Lehrnbecher","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib165","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/508774","article-title":"Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial","volume":"44","author":"Walsh","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib166","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1128\/AAC.01458-07","article-title":"Combination echinocandin-polyene treatment of murine mucormycosis","volume":"52","author":"Ibrahim","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib167","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/AAC.00868-08","article-title":"Pharmacokinetics and safety of caspofungin in neonates and infants less than 3 months of age","volume":"53","author":"S\u00e1ez-Llorens","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib168","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1128\/AAC.49.11.4536-4545.2005","article-title":"Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents","volume":"49","author":"Walsh","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib169","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1128\/AAC.01027-08","article-title":"Pharmacokinetics and safety of caspofungin in older infants and toddlers","volume":"53","author":"Neely","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib170","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/INF.0b013e3181af5a15","article-title":"Safety experience with caspofungin in pediatric patients","volume":"28","author":"Zaoutis","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/1469-0691.12371_bib171","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2141.1997.3983214.x","article-title":"Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell\u2019Adulto)","volume":"99","author":"Pagano","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1111\/1469-0691.12371_bib173","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1179\/joc.2009.21.3.322","article-title":"Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology)","volume":"21","author":"Pagano","year":"2009","journal-title":"J Chemother"},{"key":"10.1111\/1469-0691.12371_bib174","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1742-1241.2006.01145.x","article-title":"Mucormycosis-associated fungal infections in patients with haematologic malignancies","volume":"63","author":"Kara","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1111\/1469-0691.12371_bib175","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1086\/313803","article-title":"Zygomycosis in the 1990s in a tertiary-care cancer center","volume":"30","author":"Kontoyiannis","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib176","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1002\/cncr.21929","article-title":"Recombinant interferon \u03b31b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions","volume":"106","author":"Safdar","year":"2006","journal-title":"Cancer"},{"key":"10.1111\/1469-0691.12371_bib177","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1111\/j.1600-6143.2009.02754.x","article-title":"Pulmonary zygomycosis in solid organ transplant recipients in the current era","volume":"9","author":"Sun","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/1469-0691.12371_bib178","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/605445","article-title":"Zygomycosis in solid organ transplant recipients: a prospective, matched case\u2013control study to assess risks for disease and outcome","volume":"200","author":"Singh","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib179","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/TP.0b013e3181dde8fc","article-title":"Rhino-orbital-cerebral zygomycosis in solid organ transplant recipients","volume":"90","author":"Sun","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/1469-0691.12371_bib180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0039-6257(05)80041-4","article-title":"Survival factors in rhino-orbital-cerebral mucormycosis","volume":"39","author":"Yohai","year":"1994","journal-title":"Surv Ophthalmol"},{"key":"10.1111\/1469-0691.12371_bib181","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/pgmj.2003.016030","article-title":"Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes","volume":"80","author":"Bhansali","year":"2004","journal-title":"Postgrad Med J"},{"key":"10.1111\/1469-0691.12371_bib182","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF01659058","article-title":"Necrotizing lesions of soft tissues: a review","volume":"15","author":"Patino","year":"1991","journal-title":"World J Surg"},{"key":"10.1111\/1469-0691.12371_bib183","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1172\/JCI32338","article-title":"The iron chelator deferasirox protects mice from mucormycosis through iron starvation","volume":"117","author":"Ibrahim","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1111\/1469-0691.12371_bib184","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1172\/JCI42164","article-title":"The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice","volume":"120","author":"Liu","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1111\/1469-0691.12371_bib185","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/jac\/dkp426","article-title":"The iron chelator deferasirox enhances liposomal amphotericin B efficacy in treating murine invasive pulmonary aspergillosis","volume":"65","author":"Ibrahim","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12371_bib186","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1128\/AAC.00361-09","article-title":"Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosis","volume":"53","author":"Spellberg","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib187","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/jac\/dkr375","article-title":"The Deferasirox-Am-Bisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial","volume":"67","author":"Spellberg","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12371_bib188","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1128\/JCM.42.11.5400-5402.2004","article-title":"Differentiation of Rhizomucor species on the basis of their different sensitivities to lovastatin","volume":"42","author":"Lukacs","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12371_bib189","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1128\/AAC.50.1.96-103.2006","article-title":"Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole","volume":"50","author":"Chamilos","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/1469-0691.12371_bib190","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0140-6736(03)14904-5","article-title":"Glucocorticoids and invasive fungal infections","volume":"362","author":"Lionakis","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/1469-0691.12371_bib191","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1469-0691.2005.01170.x","article-title":"Hyperbaric oxygen as an adjunctive treatment for zygomycosis","volume":"11","author":"John","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12371_bib192","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1086\/496927","article-title":"Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study","volume":"41","author":"Maertens","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib193","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1469-0691.2012.03976.x","article-title":"Development of a single tube multiplex real-time PCR to detect the most clinically relevant Mucormycetes species","volume":"19","author":"Bernal-Martinez","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12371_bib194","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1093\/cid\/cit094","article-title":"Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients","volume":"56","author":"Millon","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 5","key":"10.1111\/1469-0691.12371_bib195","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1469-0691.2009.02984.x","article-title":"In vitro activity of antifungals against Zygomycetes","volume":"15","author":"Alastruey-Izquierdo","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12371_bib196","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1080\/10428190310001653691","article-title":"Improved outcome of zygomycosis in patients with hematological diseases?","volume":"45","author":"Gleissner","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/1469-0691.12371_bib197","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.diabet.2012.01.002","article-title":"Diabetes and mucormycosis: a complex interplay","volume":"38","author":"Rammaert","year":"2012","journal-title":"Diabetes Metab"},{"key":"10.1111\/1469-0691.12371_bib198","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1086\/320767","article-title":"Resolution of rhinocerebral zygomycosis associated with adjuvant administration of granulocyte\u2013macrophage colony-stimulating factor","volume":"32","author":"Garcia-Diaz","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib199","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/jinf.2001.0831","article-title":"Ten years\u2019 experience in zygomycosis at a tertiary care centre in India","volume":"42","author":"Chakrabarti","year":"2001","journal-title":"J Infect"},{"key":"10.1111\/1469-0691.12371_bib200","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1345\/aph.1R775","article-title":"Posaconazole therapeutic drug monitoring in pediatric patients and young adults with cancer","volume":"47","author":"Bernardo","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.1111\/1469-0691.12371_bib13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11046-012-9559-2","article-title":"Mucor irregularis infection and lethal midline granuloma: a case report and review of published literature","volume":"174","author":"Li","year":"2012","journal-title":"Mycopathologia"},{"key":"10.1111\/1469-0691.12371_bib14","first-page":"822","article-title":"[Quantitative real-time polymerase chain reaction for the diagnosis of invasive fungal disease]","volume":"92","author":"Lu","year":"2012","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1111\/1469-0691.12371_bib15","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1086\/600817","article-title":"Primary cutaneous zygomycosis caused by Rhizomucor variabilis: a new endemic zygomycosis? A case report and review of 6 cases reported from China","volume":"49","author":"Lu","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib16","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/cid\/cis1045","article-title":"Slowly progressive cutaneous, rhinofacial, and pulmonary mucormycosis caused by Mucor irregularis in an immunocompetent woman","volume":"56","author":"Xia","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12371_bib34","series-title":"Clinical microbiology procedures handbook","author":"Garcia","year":"2010"},{"key":"10.1111\/1469-0691.12371_bib35","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1309\/7KU5XWURYM0151YN","article-title":"Increased culture recovery of Zygomycetes under physiologic temperature conditions","volume":"127","author":"Kontoyiannis","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/1469-0691.12371_bib60","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1128\/JCM.01744-09","article-title":"Species recognition and clinical relevance of the zygomycetous genus Lichtheimia (syn. Absidia pro parte, Mycocladus)","volume":"48","author":"Alastruey-Izquierdo","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12371_bib61","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1128\/JCM.01646-10","article-title":"Molecular phylogeny and proposal of two new species of the emerging pathogenic fungus Saksenaea","volume":"48","author":"Alvarez","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1111\/1469-0691.12371_bib62","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.riam.2010.01.006","article-title":"Molecular phylogenetic diversity of the emerging mucoralean fungus Apophysomyces: proposal of three new species","volume":"27","author":"Alvarez","year":"2010","journal-title":"Rev Iberoam Micol"},{"key":"10.1111\/1469-0691.12371_bib132","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3109\/13693786.2012.673137","article-title":"Experimental murine model of disseminated infection by Saksenaea vasiformis: successful treatment with posaconazole","volume":"50","author":"Salas","year":"2012","journal-title":"Med Mycol"},{"key":"10.1111\/1469-0691.12371_bib147","doi-asserted-by":"crossref","first-page":"e785","DOI":"10.1111\/j.1439-0507.2011.02025.x","article-title":"Mucormycosis in paediatric patients: demographics, risk factors and outcome of 12 contemporary cases","volume":"54","author":"Dabritz","year":"2011","journal-title":"Mycoses"},{"key":"10.1111\/1469-0691.12371_bib133","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1093\/jac\/dks090","article-title":"Efficacy of posaconazole in a murine model of disseminated infection caused by Apophysomyces variabilis","volume":"67","author":"Salas","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12371_bib172","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/512817","article-title":"Decrease in the number of reported cases of zygomycosis among patients with diabetes mellitus: a hypothesis","volume":"44","author":"Kontoyiannis","year":"2007","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14602287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14602287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T14:48:51Z","timestamp":1648133331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14602287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":199,"alternative-id":["S1198743X14602287"],"URL":"https:\/\/doi.org\/10.1111\/1469-0691.12371","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718261013.793495483","asserted-by":"object"}]},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}